U-Neuron Biomedical Inc (TPEX:6973)
Taiwan · Delayed Price · Currency is TWD 52.70
+5.20 (10.95%)
Sep 15, 2026, 1:39 PM CST
U-Neuron Biomedical Market Cap
U-Neuron Biomedical has a market cap or net worth of 1.57 billion as of September 15, 2026. Its market cap has increased by 26.22% in one year.
Market Cap
1.57B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
52.70
ChartMarket Cap Chart
Since July 20, 2023, U-Neuron Biomedical's market cap has increased from 1.36B to 1.57B, an increase of 15.65%. That is a compound annual growth rate of 4.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 1.57B | 40.37% |
| Dec 31, 2025 | 1.12B | -9.44% |
| Dec 31, 2024 | 1.24B | -30.25% |
| Dec 29, 2023 | 1.77B | 30.43% |
| Jul 20, 2023 | 1.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Andros Pharmaceuticals Co.,Ltd | 1.69B |
| Synbio Tech | 1.55B |
| Greenyn Biotechnology | 1.54B |
| TaiRx | 1.46B |
| Advagene Biopharma | 1.46B |
| GenMont Biotech Incorporation | 1.37B |
| NeoCore Technology | 1.27B |
| Abnova (Taiwan) | 1.23B |